December 21, 2016 Non Regulatory Promore Pharma and Cellastra Inc. Announce Phase III Clinical Collaboration to Develop Therapeutic Peptide PXL01 for the US Market
July 8, 2016 Non Regulatory Promore Pharma Announces a Strategic Collaboration with Technomark Life Sciences
May 31, 2016 Non Regulatory Promore Pharma Obtains Positive Feedback in Dialogue with The Medical Products Agency of Sweden